THE PROTHROMBIN TIME IN DICOUMAROL THERAPY
Authors: F C COLEMAN
Journal: Annals of Internal Medicine (1949)

Article1 May 1949THE PROTHROMBIN TIME IN DICOUMAROL THERAPYF. C. COLEMAN, M.D.F. C. COLEMAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-30-5-895 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe identification of dicoumarol as the cause of sweet clover disease was made by Link in 1939. This disease is a hemorrhagic disease in cattle which have eaten spoiled sweet clover, and is due to a decrease in the prothrombin content of the blood. In 1941 Link reported the synthesis of dicoumarol. It could be prepared in large quantities at low cost. Within three months the first published report of its clinical use was made by Allen, Barker and Waugh. It is of therapeutic value in those diseases where intravascular clotting is present. These are, particularly, thrombosis and embolism following...Bibliography AGGELER PM: Heparin and dicoumarol—anticoagulants; their prophylactic and therapeutic uses, California and West. Med., 1946, lxiv, 71-77. Google Scholar ALLEN EV: Challenge of thrombosis and embolism of blood vessels, and clinical use of anticoagulants, Quart. Bull., Northwestern Univ. Med. School, 1946, xx, 1-7. Google Scholar ALLEN JG: Clinical value of functional tests of liver; review with special study of plasma prothrombin, Gastroenterology, 1944, iii, 490-505. Google Scholar ALLENJULIANDRAGSTEDT JGOCLR: Use of serial dilutions in determination of prothrombin by one stage technic, Arch. Surg., 1940, xli, 873-878. CrossrefGoogle Scholar BANFITANTURIBAY RFCAR: Prothrombin in preserved blood, Jr. Lab. and Clin. Med., 1945, xxx, 512-517. Google Scholar BARKER NW: Anticoagulant therapy in thrombosis and embolism, Postgrad. Med., 1947, i, 265-273. CrossrefGoogle Scholar BARKER NW: Clinical use of dicoumarol, Med. Clin. North Am., 1945, xxix, 929-935. CrossrefGoogle Scholar BARKERCROMERHURNWAUGH NWHEMJM: Use of dicoumarol in prevention of postoperative thrombosis and embolism with special reference to dosage and safe administration, Surgery, 1945, xvii, 207-217. Google Scholar BAUERLEIN TC: Failure of vitamin K as antidote in dicoumarol poisoning, Rocky Mountain Med. Jr., 1945, xlii, 950-951. Google Scholar BLACKOVERMANELVEHJEMLINK SRSCAKP: Effect of sulfaguanidine on rat growth and plasma prothrombin, Jr. Biol. Chem., 1942, cxlv, 137-143. CrossrefGoogle Scholar BRAMBELLOKER CEFF: Application of dicoumarin (3,3′-methylenebis (4-hydroxycoumarin)) in trauma and gangrene, Arch. Surg., 1944, xlviii, 1-16. CrossrefGoogle Scholar BUTT HR: Preoperative and postoperative use of vitamin K in cases of deficiency of prothrombin, Surg. Clin. North Am., 1940, xx, 1203-1210. Google Scholar CAMPBELLLINK HAKP: Studies on hemorrhagic sweet clover disease; isolation and crystallization of hemorrhagic agent, Jr. Biol. Chem., 1941, cxxxviii, 21-33. CrossrefGoogle Scholar CAMPBELLSMITHROBERTSLINK HAWKWLKP: Studies on hemorrhagic sweet clover disease; bio-assay of hemorrhagic concentrates by following prothrombin level in plasma of rabbit blood, Jr. Biol. Chem., 1941, cxxxviii, 1-20. Google Scholar COTLOVEVORZIMER EJJ: Serial prothrombin estimations in cardiac patients: diagnostic and therapeutic implications; use of dicoumarol, Ann. Int. Med., 1946, xxiv, 648-665. Google Scholar DAVIDSONMACDONALD CSH: Critical study of action of 3-3′-methylenebis (4-hydroxycoumarin) (dicoumarin), Am. Jr. Med. Sci., 1943, ccv, 24-33. CrossrefGoogle Scholar DAVIDSONFREEDMACDONALD CSJHH: Effect of vitamin K1 oxide upon anticoagulant properties of dicoumarol, Am. Jr. Med. Sci., 1945, ccx, 634-637. CrossrefGoogle Scholar DERCUM FX: Internal secretions, Med. Clin. N. Am., 1921, iv, 1141. Google Scholar DIGGS LW: Laboratory tests used in diagnosis and management of hemorrhagic diseases. In: KRACKE, R. H., editor: A Textbook of Clinical Pathology, 1938, William Wood & Co., Baltimore, Chapt. 10, pp. 162-186. Google Scholar ECKSTAM EE: Clinical use of dicoumarol; report of cases, Minnesota Med., 1944, xxvii, 455-458. Google Scholar FIELDSVEINBJORNSSONLINK JBAKP: Increased plasma fibrinogen induced by methylxanthines, Jr. Biol. Chem., 1945, clix, 525-528. CrossrefGoogle Scholar FISHER B: Correspondence, The expression of prothrombin values, Jr. Am. Med. Assoc., 1946, cxxxi, 1456. CrossrefGoogle Scholar FULLERTON HW: Estimation of prothrombin; simplified method, Lancet, 1940, ii, 195-196. CrossrefGoogle Scholar GEFTERKRAMERREINHOLD WIDWJG: Clinical experience with dicoumarol, Am. Heart Jr., 1944, xxviii, 321-331. CrossrefGoogle Scholar HOFFMAN OD CUSTER RP (Philadelphia) : Micro method for determining prothrombin time on fresh capillary blood using standard physical conditions, Am. Jr. Med. Sci., 1942, cciv, 420-430. CrossrefGoogle Scholar HURNBARKERMAGATH MNWTB: Determination of prothrombin time following administration of dicoumarol, 3,3′-methylenebis (4-hydroxycoumarin), with special reference to thromboplastin, Jr. Lab. and Clin. Med., 1945, xxx, 432-447. Google Scholar HURNBARKERMAGATH MNWTB: Prothrombin time determinations following administration of dicoumarol, with special reference to variability of thromboplastin, Proc. Staff Meet., Mayo Clin., 1944, xix, 507-512. Google Scholar HYMAN C: Dicoumarol therapy, Med. Rec., 1946, clix, 613-616. Google Scholar KATO K PONCHER HG (Chicago) : Prothrombin in blood of newborn mature and immature infants as determined by micro prothrombin test, Jr. Am. Med. Assoc., 1940, cxiv, 749-753. Google Scholar KAUMPGREENWOOD DHJH: Plasma prothrombin determination, Am. Jr. Clin. Path., 1940, x, 397-407. CrossrefGoogle Scholar KRACKE RR: Diseases of the Blood and Atlas of Hematology, Ed. 2, 1941, J. B. Lippincott Company, Philadelphia, p. 637-640. Google Scholar LINK KP: Anticoagulant dicoumarol (William Hamlin Wilder memorial lecture), Proc. Inst. Med. Chicago, 1945, xv, 370-389. Google Scholar LONGHURNBARKER MMNW: Effect of heparin on prothrombin time, Proc. Staff Meet., Mayo Clin., 1946, xxi, 225-229. Google Scholar MCCARTERBINGHAMMEYER JCJBOO: Studies on hemorrhagic agent 3,3′-methylenebis (4-hydroxycoumarin); pathologic findings after administration of dicoumarol, Am. Jr. Path., 1944, xx, 651-659. Google Scholar MAGATH TB: Technic of prothrombin time determination, Am. Jr. Clin. Path., Tech. Supp., 1939, iii, 187-189. CrossrefGoogle Scholar MEYERBINGHAMAXELROD OOJBVH: Studies on hemorrhagic agent, 3,3′-methylenebis (4-hydroxycoumarin); method of administration and dosage, Am. Jr. Med. Sci., 1942, cciv, 11-21. CrossrefGoogle Scholar NORRISRUSH RFA: Comparison of prothrombin levels of maternal and cord blood at delivery, Surg., Gynec. and Obst., 1940, lxx, 1006-1010. Google Scholar ONEALLAM WJCR: Experiments on components A and B (Quick) of prothrombin, Am. Jr. Med. Sci., 1945, ccx, 181-184. CrossrefGoogle Scholar OVERMANSTAHMANNLINK RSMAKP: Studies on hemorrhagic sweet clover disease; effect of 2-methyl-1, 4-naphthoquinone and "1"-ascorbic acid upon the action of 3,3′-methylenebis (4-hydroxycoumarin) on prothrombin time of rabbits, Jr. Biol. Chem., 1942, cxlv, 155-162. CrossrefGoogle Scholar OVERMAN RS: Studies on hemorrhagic sweet clover disease; effect of 3,3′-methylenebis (4-hydroxycoumarin) on prothrombin time of plasma of various animals, Jr. Biol. Chem., 1942, cxlii, 941-955. CrossrefGoogle Scholar PAGERUSSELL RCHK: Prothrombin estimation using Russell viper venom; simple modification of Quick's method, Jr. Lab. and Clin. Med., 1941, xxvi, 1366-1370. Google Scholar PAGEDEBEERORR RCEJML: Prothrombin studies using Russell viper venom; effect of lecithinized venom on prothrombin clotting time, Jr. Lab. and Clin. Med., 1942, xxvii, 830-834. Google Scholar PETERSGUYTHERBRAMBEL HRJRCE: Dicoumarol in acute coronary thrombosis, Jr. Am. Med. Assoc., 1946, cxxx, 398-403. CrossrefGoogle Scholar PETITBERNE DWCJ: Medical progress: Dicoumarol, California Med., 1947, lxvii, 40-44. Google Scholar PFEIFFERSAIN DBFD: Heparin and dicoumarol; collective review, Internat. Abstr. Surg., 1944, lxxviii, 109-119. Google Scholar POHLESTEWART FJJK: Study of Quick method for quantitative determination of prothrombin with suggested modifications, Am. Jr. Med. Sci., 1939, cxcviii, 622-630. CrossrefGoogle Scholar PRANDONIWRIGHT AI: Anticoagulants; heparin and the dicoumarin, 3,3′-methylenebis (4-hydroxycoumarin), Bull. New York Acad. Med., 1942, xviii, 433-458. Google Scholar QUICK AJ: Calcium factor in quantitative determination of prothrombin, Proc. Soc. Exper. Biol. and Med., 1939, xl, 206-208. CrossrefGoogle Scholar QUICK AJ: Calcium in coagulation of blood, Am. Jr. Physiol., 1940, cxxxi, 455-464. CrossrefGoogle Scholar QUICK AJ: Clinical application of hippuric acid and prothrombin tests, Am. Jr. Clin. Path., 1940, x, 222-233. CrossrefGoogle Scholar QUICK AJ: Clinical significance of prothrombin as factor in hemorrhage, Pennsylvania Med. Jr., 1939, xliii, 125-130. Google Scholar QUICK AJ: Nature of bleeding in jaundice, Jr. Am. Med. Assoc., 1938, cx, 1658-1662. CrossrefGoogle Scholar QUICK AJ: Prothrombin in hemophilia and in obstructive jaundice, Jr. Biol. Chem., 1935, cix, 73-74. Google Scholar REICHYAHREGGERS CMDC: Dicoumarol in prevention of postoperative thrombosis and pulmonary embolism, Surgery, 1945, xviii, 238-243. Google Scholar SHARPWOLTERVONDER HEIDE EAJGEC: Prothrombin in disorders of blood, Am. Jr. Clin. Path., 1944, xiv, 44-51. CrossrefGoogle Scholar SHLEVINLEDERER ELM: Uncontrollable hemorrhage after dicoumarol therapy with autopsy findings, Ann. Int. Med., 1944, xxi, 332-342. Google Scholar SMITHZIFFRENOWENHOFFMAN HPSECAGR: Clinical and experimental studies on vitamin K, Jr. Am. Med. Assoc., 1939, cxiii, 380-383. CrossrefGoogle Scholar SMITHWARNERBRINKHOUS HPEDKM: Prothrombin deficiency and bleeding tendency in liver injury (chloroform intoxication), Jr. Exper. Med., 1937, lxvi, 801-811. Google Scholar SOUTERKARK AWR: Quick's prothrombin test simplified by use of stable thromboplastin, Am. Jr. Med. Sci., 1940, cc, 603-607. CrossrefGoogle Scholar STAHMANNHUEBNERLINK MACFKP: Studies on hemorrhagic sweet clover disease; identification and synthesis of hemorrhagic agent, Jr. Biol. Chem., 1941, cxxxviii, 513-527. CrossrefGoogle Scholar STEWARTPOHLE JKFJ: Effect of calcium in quantitative determination of prothrombin, Proc. Soc. Exper. Biol. and Med., 1938, xxxix, 532-534. CrossrefGoogle Scholar SULLIVANGANGSTADLINK WREOKP: Studies on hemorrhagic sweet clover disease; effect of "1" ascorbic acid on hypoprothrombinemia induced by 3,3′-methylenebis (4-hydroxycoumarin) in guinea pig, Jr. Biol. Chem., 1943, cli, 477-485. CrossrefGoogle Scholar _____:Prothrombin deficiency bleeding, Therapeutic notes, Jan. 1940, pp. 9-14. (Pub. by Parke, Davis & Co., Detroit, Mich.) Google Scholar WRIGHT IS: Experiences with dicoumarol (3,3′-methylenebis[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction, Am. Heart Jr., 1946, xxxii, 20-31. CrossrefGoogle Scholar ZIEGLEROSTERBERGHOVIG ERAEM: Prothrombin changes in banked blood, Jr. Am. Med. Assoc., 1940, cxiv, 1341-1342. Google Scholar ZUCKER HD: Clinical experiences with dicoumarol; report of 18 cases, Jr. Am. Med. Assoc., 1944, cxxiv, 217-220. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Des Moines, Iowa*Presented before the State Divisional Meeting of the American College of Physicians in Des Moines, Iowa on September 27, 1947. Received for publication February 12, 1948.From the Department of Pathology, Mercy Hospital, Des Moines, Iowa. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 May 1949Volume 30, Issue 5Page: 895-902KeywordsBloodProthrombin timeThrombosis ePublished: 1 December 2008 Issue Published: 1 May 1949 Copyright & PermissionsCopyright, 1949, by The American College of PhysiciansPDF downloadLoading ...